Targretin

Active Ingredient(s): Bexarotene
FDA Approved: * December 29, 1999
Pharm Company: * LIGAND
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Targretin Overview

Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent approved by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).[1] It is a third-generation retinoid. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism 6 Physical properties 7 History 8 References Medical uses Bexarotene is indicated for...

Read more Targretin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bexarotene

Recent Targretin Forums: RSS Feed

Targretin for Cutaneous T Cell Lymphoma

My husband has CTCL and is being told to take Targretin. Can anyone tell me if they have taken it and what side effects they had? Thank you ## Lois, There is an online support group of CTCL patients, many of whom are on Taragretin. They will be happy to share their experiences. Go to Association of Cancer Online Resources and look for the CTCL-MF group. ## Thank you, Judy for that very helpful post. It seems we haven't had a lot of people posting on here that have been using it. We do, however, have more information on the medication here: Can anyone post about experience using this drug?

Updated

Possible Dosages for this and Related Drugs:

Bexarotene
  • Capsule: 75mg
  • Gel: 1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Targretin: (5 results)

Sorted by National Drug Code
  • 0187-5525 Targretin 1 g/100g Topical Gel by Valeant Pharmaceuticals North America LLC
  • 0187-5526 Targretin 75 mg/1 Oral Capsule, Liquid Filled by Valeant Pharmaceuticals North America LLC
  • 62856-602 Targretin 75 mg Oral Capsule by Eisai Inc.
  • 62856-604 Targretin 1 g/100g Topical Gel by Eisai Inc.
  • 64365-502 Targretin 75 mg Oral Capsule by Cardinal Health

Other drugs which contain Bexarotene or a similar ingredient: (1 result)

Related Targretin Topics:

Targretin for Cutaneous T Cell Lymphoma
My husband has CTCL and is being told to take Targretin. Can anyone tell me if they have taken it and what side effects ... 2 replies






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA